S. Owens

发表

Perfusion of 99Tcm‐labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that CD105 is a promising vascular target

S. O'dwyer, Shant Kumar, Chenggang Li, 2004, International journal of cancer.

Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease.

C. Fichtenbaum, J. Currier, J. Feinberg, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087.

W. K. Henry, C. Fichtenbaum, S. Evans, 2005, AIDS research and human retroviruses.

Prevention of Relapse of Histoplasmosis with Itraconazole in Patients with the Acquired Immunodeficiency Syndrome

M. Wulfsohn, M. Saag, K. Squires, 1993, Annals of Internal Medicine.

Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.

K. Tashima, K. Yarasheski, S. Evans, 2009, The Journal of antimicrobial chemotherapy.

Viability and Functional Activity of Cryopreserved Mononuclear Cells

M. Hirsch, B. Polsky, A. Weinberg, 2000, Clinical Diagnostic Laboratory Immunology.

The clinical of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no or

M. Jacobson, C. Benson, D. Wohl, 2013 .

Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study

S. Owens, I. Adamsons, J. Hutzelmann, 1998 .

Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.

C. Yiannoutsos, C. Fichtenbaum, D. Skiest, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group.

D. Kuritzkes, C. Farthing, R. Steigbigel, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients

Jihnhee Yu, K. Wood, K. Raghavendran, 2009, Critical care.

Low Rate of CMV End-Organ Disease in HIV-Infected Patients Despite Low CD4+ Cell Counts and CMV Viremia: Results of ACTG Protocol A5030

C. Crumpacker, S. Spector, D. Jabs, 2009, HIV clinical trials.

A Randomized, Double-Blind Trial of Valaciclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection

D. Cooper, M. Youle, P. Griffiths, 1998 .

A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.

M. Youle, P. Griffiths, M. Gill, 1998, The Journal of infectious diseases.

Phase II dose‐ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG Protocol 093)

Roger B. Davis, M. Wulfsohn, C. Crumpacker, 1994 .

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

M. Jacobson, R. Pollard, P. Pavan, 1997, The Lancet.